Products
HemaFus BCR-ABL1(P210) Fusion Gene Quantitative Detection Kit
Cat. No.:
T0296
Spec:
24 Tests/Kit
Product description
Parameters
Method
In this method, RNA is isolated and purified from leukocytes in peripheral blood or bone marrow samples, and cDNA is obtained by reverse transcription to detect b3a2 and b2a2 types of BCR-ABL1 fusion gene (P210) by real-time Q-PCR. BCR and ABL1 fusion transcripts (P210) are shown in Figure 1.
Figure 1
Quantitative Kit Detection Results
Specimen Requirements
Peripheral blood or bone marrow (3–5 mL) is collected in the EDTA tube and stored at 2–8 °C for not more than 5 days. RNA extraction is performed within 5 days.
References
[1] Leukemia, 2001, 15(4):575-582.
[2] Leukemia, 2003, 17(12):2318-2357.
[3] Leukemia (1999) 13, 1901‒1928.
Ordering Information
| Cat. No. | Product | Strength |
| T0296 |
HemaFus BCR/ABL1(P210) Fusion Gene Quantitative Detection Kit
|
24 Tests/Kit |
Scan the QR code to read on your phone
